UK Markets open in 5 hrs 4 mins
  • NIKKEI 225

    +240.63 (+0.85%)

    +112.23 (+0.46%)

    +1.01 (+1.20%)

    +4.40 (+0.24%)
  • DOW

    -201.79 (-0.56%)

    -652.03 (-2.06%)
  • CMC Crypto 200

    -9.01 (-0.88%)
  • Nasdaq

    +86.95 (+0.59%)
  • ^FTAS

    +35.99 (+0.85%)

The United States Smart Drugs & Pills Market Will Grow to USD 2,419.22 Million by 2026, at a CAGR of 23.38%

·5-min read

Dublin, Dec. 20, 2021 (GLOBE NEWSWIRE) -- The "Smart Drugs & Pills Market Research Report by Target Area, End-user, Application, and State - United States Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to's offering.

The United States Smart Drugs & Pills Market size was estimated at USD 685.62 million in 2020, is expected to reach USD 867.25 million in 2021, and is projected to grow at a CAGR of 23.38% reaching USD 2,419.22 million by 2026.

Market Statistics

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage

This research report categorizes the Smart Drugs & Pills to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Target Area, the market was studied across Esophagus, Large Intestine, Small Intestine, and Stomach.

  • Based on End-user, the market was studied across Diagnostic Centers, Hospitals, and Research Institutes.

  • Based on Application, the market was studied across Capsule Endoscopy, Drug Delivery, and Patient Monitoring.

  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Companies Mentioned

  • Acamp

  • Bio-Images Research Limited

  • Boston Scientific Corporation

  • CapsoVision, Inc.

  • Cerner Corporation

  • Fujifilm Holdings Corporation

  • GE Healthcare

  • Given Imaging, Inc.

  • Karl Storz Gmbh & Co. KG

  • Medimetrics S.A. de C.V.

  • MediSafe

  • Medtronic

  • Olympus Corporation

  • Pentax Medical Company

  • Proteus Digital Health

Cumulative Impact of COVID-19
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The analyst's ongoing research amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Smart Drugs & Pills Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitors' strength and weakness thereby, providing insights to enhance product and service.

Key Topics Covered:

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Smart Drugs & Pills Market, by Target Area
6.1. Introduction
6.2. Esophagus
6.3. Large Intestine
6.4. Small Intestine
6.5. Stomach

7. Smart Drugs & Pills Market, by End-user
7.1. Introduction
7.2. Diagnostic Centers
7.3. Hospitals
7.4. Research Institutes

8. Smart Drugs & Pills Market, by Application
8.1. Introduction
8.2. Capsule Endoscopy
8.3. Drug Delivery
8.4. Patient Monitoring

9. California Smart Drugs & Pills Market

10. Florida Smart Drugs & Pills Market

11. Illinois Smart Drugs & Pills Market

12. New York Smart Drugs & Pills Market

13. Ohio Smart Drugs & Pills Market

14. Pennsylvania Smart Drugs & Pills Market

15. Texas Smart Drugs & Pills Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, by Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition

17. Company Usability Profiles

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting